MiNK Therapeutics (INKT) Misses Q3 EPS by 65c

MiNK Therapeutics (NASDAQ: INKT) reported Q3 EPS of ($0.65).

For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.

You May Also Be Interested In

• Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
• Elastic NV. (ESTC) PT Raised to $107 at Stifel as Sales Revenue Accelerates
• Cantor Fitzgerald Reiterates Overweight Rating on Affirm Holdings (AFRM) Following Earnings